Previous close | 16.45 |
Open | 16.65 |
Bid | 16.45 x 0 |
Ask | 16.75 x 0 |
Day's range | 16.65 - 16.65 |
52-week range | 13.80 - 25.60 |
Volume | |
Avg. volume | 17 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
HAMBURG, Germany, January 25, 2023--Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd. (JSE: SOL; NYSE: SSL), announced today a collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs). This collaboration expands the partnership announced in March 2022 between the two companies to develop and commercialise another biosurfactant product, sophorolipids.
PRODUCTION AND SALES METRICS FOR THE SIX MONTHS ENDED 31 DECEMBER 2022
TRADING STATEMENT FOR THE SIX MONTHS ENDING 31 DECEMBER 2022